We are also offering the vaccine to anyone aged 75 or over, this includes anyone who will turn 75 by the 17th June 2025.

Immunosuppressed patients are those defined in Covid 19- the Green Book Chapter 14a; tables 3 & 4

• Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, patients
  undergoing radical radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients, HIV infection at all stages,
  multiple myeloma or genetic disorders affecting the immune system (e.g.IRAK-4, NEMO, complement disorder, SCID).
  Individuals who are receiving immunosuppressive or immunomodulating biological therapy including, but not limited to, anti-TNF, alemtuzumab,
  ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as
  cyclophosphamide and mycophenolate mofetil. Individuals treated with or likely to be treated with systemic steroids for
  more than a month at a dose equivalent to prednisolone at 20mg or more per day for adults. Anyone with a history of haematological malignancy, including leukaemia,lymphoma, and myeloma. Those who require long term immunosuppressive treatment for conditions
  including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, scleroderma and psoriasis.Some immunosuppressed patients may have a suboptimal immunological response to the vaccine.